Qifeng Zhuo

Shanghai Cancer Institute

Papers

1

Total Citations

10

H-Index

1

About

Dr. Qifeng Zhuo is a pioneering pancreatic surgeon whose work has fundamentally redefined the boundaries of minimally invasive tumor resection. Based at Fudan University Shanghai Cancer Center, his primary research focuses on advancing laparoscopic and robotic enucleation (LEN/REN) techniques for pancreatic neoplasms. His landmark 2023 study, which has already garnered 10 citations, shattered a long-held surgical dogma by demonstrating that tumors involving the main pancreatic duct (MPD) are no longer an absolute contraindication for enucleation. By meticulously analyzing clinical data from consecutive patients treated between 2019 and 2021, Dr. Zhuo proved that parenchyma-sparing surgery can be performed safely even in these complex cases, dramatically expanding treatment options and preserving pancreatic function for patients who would otherwise face major resections. This breakthrough challenges conventional surgical boundaries and offers a less invasive path for carefully selected patients. His work continues to influence operative guidelines and inspire further innovation in organ-sparing pancreatic surgery, marking him as a rising leader in the field of hepatobiliary and pancreatic minimally invasive surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive enucleation of pancreatic tumors: The main pancreatic duct is no longer a restricted area
10 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Shanghai Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago